XML 88 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Loans and Allowance for Loan Losses
3 Months Ended
Mar. 31, 2013
Receivables [Abstract]  
Loans and Allowance for Loan Losses
Loans and Allowance for Loan Losses
We serve a variety of commercial clients in the technology, life science, venture capital/private equity and premium wine industries. Our technology clients generally tend to be in the industries of hardware (semiconductors, communications and electronics), software and related services, and clean technology. Because of the diverse nature of clean technology products and services, for our loan-related reporting purposes, cleantech-related loans are reported under our hardware, software, life science and other commercial loan categories, as applicable. Our life science clients are concentrated in the medical devices and biotechnology sectors. Loans made to venture capital/private equity firm clients typically enable them to fund investments prior to their receipt of funds from capital calls. Loans to the premium wine industry focus on vineyards and wineries that produce grapes and wines of high quality.
In addition to commercial loans, we make consumer loans through SVB Private Bank and provide real estate secured loans to eligible employees through our EHOP. Our private banking clients are primarily venture capital/private equity professionals. These products and services include real estate secured home equity lines of credit, which may be used to finance real estate investments and loans used to purchase, renovate or refinance personal residences. These products and services also include restricted stock purchase loans and capital call lines of credit.
We also provide community development loans made as part of our responsibilities under the Community Reinvestment Act. These loans are included within “Construction loans” below and are primarily secured by real estate.
The composition of loans, net of unearned income of $78 million and $77 million at March 31, 2013 and December 31, 2012, respectively, is presented in the following table:
(Dollars in thousands)
 
March 31, 2013
 
December 31, 2012
Commercial loans:
 
 
 
 
Software
 
$
3,455,602

 
$
3,261,489

Hardware
 
1,220,691

 
1,118,370

Venture capital/private equity
 
1,322,123

 
1,732,699

Life science
 
1,017,859

 
1,066,199

Premium wine
 
139,017

 
143,511

Other
 
342,129

 
315,453

Total commercial loans
 
7,497,421

 
7,637,721

Real estate secured loans:
 
 
 
 
Premium wine (1)
 
464,713

 
413,513

Consumer loans (2)
 
724,894

 
685,300

Total real estate secured loans
 
1,189,607

 
1,098,813

Construction loans
 
58,573

 
65,742

Consumer loans
 
99,289

 
144,657

Total loans, net of unearned income (3)
 
$
8,844,890

 
$
8,946,933

 
 
(1)
Included in our premium wine portfolio are gross construction loans of $133 million and $148 million at March 31, 2013 and December 31, 2012, respectively.
(2)
Consumer loans secured by real estate at March 31, 2013 and December 31, 2012 were comprised of the following:
(Dollars in thousands)
 
March 31, 2013
 
December 31, 2012
Loans for personal residence
 
$
541,115

 
$
503,378

Loans to eligible employees
 
112,314

 
110,584

Home equity lines of credit
 
71,465

 
71,338

Consumer loans secured by real estate
 
$
724,894

 
$
685,300


(3)
Included within our total loan portfolio are credit card loans of $77 million and $64 million at March 31, 2013 and December 31, 2012, respectively.
Credit Quality
The composition of loans, net of unearned income of $78 million and $77 million at March 31, 2013 and December 31, 2012, respectively, broken out by portfolio segment and class of financing receivable is as follows:
(Dollars in thousands)
 
March 31,
2013
 
December 31,
2012
Commercial loans:
 
 
 
 
Software
 
$
3,455,602

 
$
3,261,489

Hardware
 
1,220,691

 
1,118,370

Venture capital/private equity
 
1,322,123

 
1,732,699

Life science
 
1,017,859

 
1,066,199

Premium wine
 
603,730

 
557,024

Other
 
400,702

 
381,195

Total commercial loans
 
8,020,707

 
8,116,976

Consumer loans:
 
 
 
 
Real estate secured loans
 
724,894

 
685,300

Other consumer loans
 
99,289

 
144,657

Total consumer loans
 
824,183

 
829,957

Total loans, net of unearned income
 
$
8,844,890

 
$
8,946,933


The following table summarizes the aging of our gross loans, broken out by portfolio segment and class of financing receivable as of March 31, 2013 and December 31, 2012:
(Dollars in thousands)
 
30 - 59
  Days Past  
Due
 
60 - 89
  Days Past  
Due
 
Greater
Than 90
  Days Past  
Due
 
  Total Past  
Due
 
Current  
 
  Loans Past Due  
90 Days or
More Still
Accruing
Interest
March 31, 2013:
 
 
 
 
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
 
Software
 
$
2,739

 
$
1,493

 
$
5

 
$
4,237

 
$
3,480,632

 
$
5

Hardware
 
4,034

 
19

 
31

 
4,084

 
1,206,431

 
31

Venture capital/private equity
 
84

 
1

 

 
85

 
1,335,476

 

Life science
 
5,886

 
220

 

 
6,106

 
1,021,715

 

Premium wine
 
1,700

 

 

 
1,700

 
600,383

 

Other
 
185

 

 

 
185

 
398,877

 

Total commercial loans
 
14,628

 
1,733

 
36

 
16,397

 
8,043,514

 
36

Consumer loans:
 
 
 
 
 
 
 
 
 
 
 
 
Real estate secured loans
 
605

 

 

 
605

 
719,801

 

Other consumer loans
 
385

 

 

 
385

 
97,781

 

Total consumer loans
 
990

 

 

 
990

 
817,582

 

Total gross loans excluding impaired loans
 
15,618

 
1,733

 
36

 
17,387

 
8,861,096

 
36

Impaired loans
 
2,459

 
1,740

 
13,929

 
18,128

 
26,218

 

Total gross loans
 
$
18,077

 
$
3,473

 
$
13,965

 
$
35,515

 
$
8,887,314

 
$
36

December 31, 2012:
 
 
 
 
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
 
 
 
 
Software
 
$
5,890

 
$
238

 
$
19

 
$
6,147

 
$
3,284,489

 
$
19

Hardware
 
167

 
32

 

 
199

 
1,107,422

 

Venture capital/private equity
 
7

 

 

 
7

 
1,749,896

 

Life science
 
207

 
117

 

 
324

 
1,076,468

 

Premium wine
 

 

 

 

 
554,886

 

Other
 
280

 

 

 
280

 
378,619

 

Total commercial loans
 
6,551

 
387

 
19

 
6,957

 
8,151,780

 
19

Consumer loans:
 
 
 
 
 
 
 
 
 
 
 
 
Real estate secured loans
 

 

 

 

 
683,254

 

Other consumer loans
 
111

 

 

 
111

 
143,867

 

Total consumer loans
 
111

 

 

 
111

 
827,121

 

Total gross loans excluding impaired loans
 
6,662

 
387

 
19

 
7,068

 
8,978,901

 
19

Impaired loans
 
3,901

 
9,676

 
2,269

 
15,846

 
22,433

 

Total gross loans
 
$
10,563

 
$
10,063

 
$
2,288

 
$
22,914

 
$
9,001,334

 
$
19


The following table summarizes our impaired loans as they relate to our allowance for loan losses, broken out by portfolio segment and class of financing receivable as of March 31, 2013 and December 31, 2012:
(Dollars in thousands)
 
Impaired loans for  
which there is a
related allowance
for loan losses
 
Impaired loans for  
which there is no
related allowance
for loan losses
 
Total carrying value of impaired loans
 
Total unpaid
principal of impaired loans    
March 31, 2013:
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
Software
 
$
6,094

 
$

 
$
6,094

 
$
6,196

Hardware
 
20,722

 
1,944

 
22,666

 
41,943

Life Science
 
454

 

 
454

 
454

Premium wine
 

 
4,303

 
4,303

 
4,731

Other
 

 
5,294

 
5,294

 
10,008

Total commercial loans
 
27,270

 
11,541

 
38,811

 
63,332

Consumer loans:
 
 
 
 
 
 
 
 
Real estate secured loans
 
2,771

 
1,672

 
4,443

 
9,650

Other consumer loans
 
1,092

 

 
1,092

 
1,310

Total consumer loans
 
3,863

 
1,672

 
5,535

 
10,960

Total
 
$
31,133

 
$
13,213

 
$
44,346

 
$
74,292

December 31, 2012:
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
Software
 
$
3,191

 
$
72

 
$
3,263

 
$
4,475

Hardware
 
21,863

 

 
21,863

 
27,876

Life science
 

 

 

 

Premium wine
 

 
4,398

 
4,398

 
4,716

Other
 

 
5,415

 
5,415

 
9,859

Total commercial loans
 
25,054

 
9,885

 
34,939

 
46,926

Consumer loans:
 
 
 
 
 
 
 
 
Real estate secured loans
 

 
2,239

 
2,239

 
7,185

Other consumer loans
 
1,101

 

 
1,101

 
1,300

Total consumer loans
 
1,101

 
2,239

 
3,340

 
8,485

Total
 
$
26,155

 
$
12,124

 
$
38,279

 
$
55,411


The following table summarizes our average impaired loans, broken out by portfolio segment and class of financing receivable during the three months ended March 31, 2013 and 2012:
 
 
Three months ended March 31,
(Dollars in thousands)
 
2013
 
2012
Average impaired loans:
 
 
 
 
Commercial loans:
 
 
 
 
Software
 
$
4,114

 
$
1,536

Hardware
 
23,632

 
12,262

Life science
 
314

 
146

Premium wine
 
4,336

 
3,383

Other
 
5,218

 
4,644

Total commercial loans
 
37,614

 
21,971

Consumer loans:
 
 
 
 
Real estate secured loans
 
2,676

 
12,847

Other consumer loans
 
1,129

 
3,019

Total consumer loans
 
3,805

 
15,866

Total average impaired loans
 
$
41,419

 
$
37,837


The following tables summarize the activity relating to our allowance for loan losses for the three months ended March 31, 2013 and 2012, broken out by portfolio segment:
Three months ended March 31, 2013 (dollars in thousands)
 
Beginning Balance December 31, 2012
 
Charge-offs
 
Recoveries
 
Provision for
(Reduction of) Loan Losses
 
Ending Balance March 31, 2013
Commercial loans:
 
 
 
 
 
 
 
 
 
 
Software
 
$
42,648

 
$
(1,518
)
 
$
242

 
$
3,638

 
$
45,010

Hardware
 
29,761

 
(1,997
)
 
446

 
(341
)
 
27,869

Venture capital/private equity
 
9,963

 

 

 
519

 
10,482

Life science
 
13,606

 
(2,070
)
 
203

 
2,207

 
13,946

Premium wine
 
3,523

 

 
90

 
86

 
3,699

Other
 
3,912

 
(41
)
 
6

 
98

 
3,975

Total commercial loans
 
103,413

 
(5,626
)
 
987

 
6,207

 
104,981

Consumer loans
 
7,238

 

 
380

 
(394
)
 
7,224

Total allowance for loan losses
 
$
110,651

 
$
(5,626
)
 
$
1,367

 
$
5,813

 
$
112,205

 
 
 
 
 
 
 
 
 
 
 
Three months ended March 31, 2012 (dollars in thousands)
 
Beginning Balance December 31, 2011
 
Charge-offs
 
Recoveries
 
(Reduction of)Provision for
 Loan Losses
 
Ending Balance March 31, 2012
Commercial loans:
 
 
 
 
 
 
 
 
 
 
Software
 
$
38,263

 
$
(859
)
 
$
2,759

 
$
(4,738
)
 
$
35,425

Hardware
 
16,810

 
(3,848
)
 
105

 
17,281

 
30,348

Venture capital/private equity
 
7,319

 

 

 
(105
)
 
7,214

Life science
 
10,243

 
(113
)
 
221

 
(59
)
 
10,292

Premium wine
 
3,914

 

 
78

 
(254
)
 
3,738

Other
 
5,817

 
(2,170
)
 
44

 
1,111

 
4,802

Total commercial loans
 
82,366

 
(6,990
)
 
3,207

 
13,236

 
91,819

Consumer loans
 
7,581

 

 
229

 
1,293

 
9,103

Total allowance for loan losses
 
$
89,947

 
$
(6,990
)
 
$
3,436

 
$
14,529

 
$
100,922

 
 
 
 
 
 
 
 
 
 
 

The following table summarizes the allowance for loan losses individually and collectively evaluated for impairment as of March 31, 2013 and December 31, 2012, broken out by portfolio segment:
 
 
March 31, 2013
 
December 31, 2012
(Dollars in thousands)
 
Individually Evaluated for  
Impairment
 
Collectively Evaluated for  
Impairment
 
Individually
Evaluated for  
Impairment
 
Collectively
Evaluated for  
Impairment
Commercial loans:
 
 
 
 
 
 
 
 
Software
 
$
2,087

 
$
42,923

 
$
762

 
$
41,886

Hardware
 
5,016

 
22,853

 
5,251

 
24,510

Venture capital/private equity
 

 
10,482

 

 
9,963

Life science
 
201

 
13,745

 

 
13,606

Premium wine
 

 
3,699

 

 
3,523

Other
 

 
3,975

 

 
3,912

Total commercial loans
 
7,304

 
97,677

 
6,013

 
97,400

Consumer loans
 
424

 
6,800

 
248

 
6,990

Total allowance for loan losses
 
$
7,728

 
$
104,477

 
$
6,261

 
$
104,390


Credit Quality Indicators
For each individual client, we establish an internal credit risk rating for that loan, which is used for assessing and monitoring credit risk as well as performance of the loan and the overall portfolio. Our internal credit risk ratings are also used to summarize the risk of loss due to failure by an individual borrower to repay the loan. For our internal credit risk ratings, each individual loan is given a risk rating of 1 through 10. Loans risk-rated 1 through 4 are performing loans and translate to an internal rating of “Pass”, with loans risk-rated 1 being cash secured. Loans risk-rated 5 through 7 are performing loans, however, we consider them as demonstrating higher risk which requires more frequent review of the individual exposures; these translate to an internal rating of “Performing (Criticized)”. A majority of our Performing (Criticized) loans are from our SVB Accelerator practice, serving our emerging or early stage clients. Loans risk-rated 8 and 9 are loans that are considered to be impaired and are on nonaccrual status. Loans are placed on nonaccrual status when they become 90 days past due as to principal or interest payments (unless the principal and interest are well secured and in the process of collection), or when we have determined, based upon most recent available information, that the timely collection of principal or interest is not probable; these loans are deemed “impaired” (For further description of nonaccrual loans, refer to Note 2—“Summary of Significant Accounting Policies” under Part II, Item 8 of our 2012 Form 10-K). Loans rated 10 are charged-off and are not included as part of our loan portfolio balance. We review our credit quality indicators for performance and appropriateness of risk ratings as part of our evaluation process for our allowance for loan losses. The following table summarizes the credit quality indicators, broken out by portfolio segment and class of financing receivables as of March 31, 2013 and December 31, 2012:
(Dollars in thousands)
 
Pass
 
  Performing  
  (Criticized)  
 
Impaired  
 
Total
March 31, 2013:
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
Software
 
$
3,250,004

 
$
234,865

 
$
6,094

 
$
3,490,963

Hardware
 
1,084,742

 
125,773

 
22,666

 
1,233,181

Venture capital/private equity
 
1,334,740

 
821

 

 
1,335,561

Life science
 
916,649

 
111,172

 
454

 
1,028,275

Premium wine
 
590,448

 
11,635

 
4,303

 
606,386

Other
 
382,874

 
16,188

 
5,294

 
404,356

Total commercial loans
 
7,559,457

 
500,454

 
38,811

 
8,098,722

Consumer loans:
 
 
 
 
 
 
 
 
Real estate secured loans
 
700,850

 
19,556

 
4,443

 
724,849

Other consumer loans
 
91,988

 
6,178

 
1,092

 
99,258

Total consumer loans
 
792,838

 
25,734

 
5,535

 
824,107

Total gross loans
 
$
8,352,295

 
$
526,188

 
$
44,346

 
$
8,922,829

December 31, 2012:
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
Software
 
$
3,050,449

 
$
240,187

 
$
3,263

 
$
3,293,899

Hardware
 
970,802

 
136,819

 
21,863

 
1,129,484

Venture capital/private equity
 
1,748,663

 
1,240

 

 
1,749,903

Life science
 
956,276

 
120,516

 

 
1,076,792

Premium wine
 
545,697

 
9,189

 
4,398

 
559,284

Other
 
360,291

 
18,608

 
5,415

 
384,314

Total commercial loans
 
7,632,178

 
526,559

 
34,939

 
8,193,676

Consumer loans:
 
 
 
 
 
 
 
 
Real estate secured loans
 
663,911

 
19,343

 
2,239

 
685,493

Other consumer loans
 
132,818

 
11,160

 
1,101

 
145,079

Total consumer loans
 
796,729

 
30,503

 
3,340

 
830,572

Total gross loans
 
$
8,428,907

 
$
557,062

 
$
38,279

 
$
9,024,248


TDRs
As of March 31, 2013 we had 20 TDRs with a total carrying value of $33.9 million where concessions have been granted to borrowers experiencing financial difficulties, in an attempt to maximize collection. There were unfunded commitments available for funding of $0.5 million to the clients associated with these TDRs as of March 31, 2013. The following table summarizes our loans modified in TDRs, broken out by portfolio segment and class of financing receivables at March 31, 2013 and December 31, 2012:
(Dollars in thousands)
 
March 31, 2013
 
December 31, 2012
Loans modified in TDRs:
 
 
 
 
Commercial loans:
 
 
 
 
Software
 
$
1,751

 
$
2,021

Hardware
 
19,749

 
20,514

Venture capital/ private equity
 
821

 

Life science
 
454

 

Premium wine
 
2,561

 
2,593

Other
 
5,749

 
5,900

Total commercial loans
 
31,085

 
31,028

Consumer loans:
 
 
 
 
Real estate secured loans
 
1,753

 
2,199

Other consumer loans
 
1,092

 
1,101

Total consumer loans
 
2,845

 
3,300

Total
 
$
33,930

 
$
34,328


The following table summarizes the recorded investment in loans modified in TDRs, broken out by portfolio segment and class of financing receivable, for modifications made during the three months ended March 31, 2013 and 2012:
 
 
Three months ended March 31,
(Dollars in thousands)
 
2013
 
2012
Loans modified in TDRs during the period:
 
 
 
 
Commercial loans:
 
 
 
 
Software
 
$

 
$
600

Venture capital/ private equity
 
821

 

Life science
 
454

 

Premium wine
 

 
405

Other
 

 
2,416

Total commercial loans
 
1,275

 
3,421

Consumer loans:
 
 
 
 
Real estate secured loans
 

 
249

Other consumer loans
 
100

 
36

Total consumer loans
 
100

 
285

Total loans modified in TDR’s during the period (1)
 
$
1,375

 
$
3,706

 
 
(1)
During the three months ended March 31, 2013, we had no partial charge-offs of loans classified as TDRs. There were partial charge-offs of $0.8 million on loans classified as TDRs during the three months ended March 31, 2012.
During the three months ended March 31, 2013, new TDRs of $1.4 million were modified through payment deferrals granted to our clients and no principal or interest was forgiven. During the three months ended March 31, 2012, new TDRs totaling $2.9 million and $0.6 million were modified through payment deferrals and forgiveness of principal, respectively.
The related allowance for loan losses for the majority of our TDRs is determined on an individual basis by comparing the carrying value of the loan to the present value of the estimated future cash flows, discounted at the pre-modification contractual interest rate. For certain TDRs, the related allowance for loan losses is determined based on the fair value of the collateral if the loan is collateral dependent.
The following table summarizes the recorded investment in loans modified in TDRs within the previous 12 months that subsequently defaulted during the three months ended March 31, 2013 and 2012, broken out by portfolio segment and class of financing receivable:
 
 
Three months ended March 31,
(Dollars in thousands)
 
2013
 
2012
TDRs modified within the previous 12 months that defaulted during the period:
 
 
 
 
Commercial loans:
 
 
 
 
Software
 
$

 
$
600

Hardware
 
125

 

Other
 
2,750

 

Total commercial loans
 
2,875

 
600

Consumer loans:
 
 
 
 
Real estate secured loans
 
247

 
249

Other consumer loans
 

 
36

Total consumer loans
 
247

 
285

Total TDRs modified within the previous 12 months that defaulted in the period
 
$
3,122

 
$
885


Charge-offs and defaults on previously restructured loans are evaluated to determine the impact to the allowance for loan losses, if any. The evaluation of these defaults may impact the assumptions used in calculating the reserve on other TDRs and impaired loans as well as management’s overall outlook of macroeconomic factors that affect the reserve on the loan portfolio as a whole. After evaluating the charge-offs and defaults experienced on our TDRs we determined that no change to our reserving methodology was necessary to determine the allowance for loan losses as of March 31, 2013.